Penserra Capital Management LLC Relmada Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$16.93 - $26.82 $6,772 - $10,728	-400 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$21.86 - $34.77 $437 - $695	20 Added 5.26%	400 $10,000
Q2 2021 Aug 12, 2021	BUY	$29.55 - $39.15 $295 - $391	10 Added 2.7%	380 $12,000
Q1 2021 May 13, 2021	SELL	$31.52 - $39.28 $157 - $196	-5 Reduced 1.33%	370 $13,000
Q4 2020 Feb 12, 2021	BUY	$29.88 - $39.8 $11,205 - $14,924	375 New	375 $12,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.3M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.